Your fact-checks will appear here
The use of FOIA litigation to compel the release of vaccine trial data, resulting in the disclosure of a key Pfizer trial dataset in 2023.
Independent researchers and public-health advocates have repeatedly flagged that raw, participant‑level datasets from several high‑profile COVID‑19 vaccine trials have not been made publicly available...
The most recent documented release of a key, participant‑level clinical trial dataset from a vaccine manufacturer occurred when the FDA included the Pfizer pivotal trial ADSL (subject‑level analysis) ...
Pfizer and Moderna made their phase‑3 trial protocols publicly available early in the pandemic, enabling external scrutiny; however, access to the full, patient‑level trial datasets has been limited a...